跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SYLVANT siltuximab (rmc) 400mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
SYLVANT siltuximab (rmc) 400mg powder for injection vial
Approved
STANDARD
SYLVANT siltuximab (rmc) 400mg powder for injection vial
Recordati Rare Diseases Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
b406d75ccb6abce1
Company
Recordati Rare Diseases Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b406d75ccb6abce1
Product Name
SYLVANT siltuximab (rmc) 400mg powder for injection vial
Artg Id
229997
Artg Name
SYLVANT siltuximab (rmc) 400mg powder for injection vial
Sponsor
Recordati Rare Diseases Australia Pty Ltd
Company Detail Path
/organization/recordati-rare-diseases-australia-pty-ltd
Artg Date
2015-08-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a68f16f859a77466a03c12270eff6005.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/be503226c051b88205cb23d04aefc2f6.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
b406d75ccb6abce1
Type
Standard
Back to TGA Approvals
